JP2020514369A - リシルオキシダーゼ様２アッセイ - Google Patents

リシルオキシダーゼ様２アッセイ Download PDF

Info

Publication number
JP2020514369A
JP2020514369A JP2019550787A JP2019550787A JP2020514369A JP 2020514369 A JP2020514369 A JP 2020514369A JP 2019550787 A JP2019550787 A JP 2019550787A JP 2019550787 A JP2019550787 A JP 2019550787A JP 2020514369 A JP2020514369 A JP 2020514369A
Authority
JP
Japan
Prior art keywords
loxl2
antibody
cancer
assay
sample
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2019550787A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020514369A5 (https=
Inventor
オースネス−レーミング，ディアーナ
カルスダル，モルテン
ニールセン，シーネ，ホルム
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nordic Bioscience AS
Original Assignee
Nordic Bioscience AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nordic Bioscience AS filed Critical Nordic Bioscience AS
Publication of JP2020514369A publication Critical patent/JP2020514369A/ja
Publication of JP2020514369A5 publication Critical patent/JP2020514369A5/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against enzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/33—Crossreactivity, e.g. for species or epitope, or lack of said crossreactivity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/902—Oxidoreductases (1.)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
JP2019550787A 2017-03-16 2018-03-14 リシルオキシダーゼ様２アッセイ Pending JP2020514369A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1704206.0 2017-03-16
GBGB1704206.0A GB201704206D0 (en) 2017-03-16 2017-03-16 Lysyl oxidase like-2 assay
PCT/EP2018/056364 WO2018167132A1 (en) 2017-03-16 2018-03-14 Lysyl oxidase like-2 assay

Publications (2)

Publication Number Publication Date
JP2020514369A true JP2020514369A (ja) 2020-05-21
JP2020514369A5 JP2020514369A5 (https=) 2021-04-22

Family

ID=58688361

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019550787A Pending JP2020514369A (ja) 2017-03-16 2018-03-14 リシルオキシダーゼ様２アッセイ

Country Status (5)

Country Link
US (1) US20200123272A1 (https=)
EP (1) EP3596127A1 (https=)
JP (1) JP2020514369A (https=)
GB (1) GB201704206D0 (https=)
WO (1) WO2018167132A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12578335B2 (en) 2020-02-05 2026-03-17 Syntara Limited Bioprobes for lysyl oxidases and uses thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014523521A (ja) * 2011-06-01 2014-09-11 ギリアード バイオロジックス， インコーポレイテッド リシルオキシダーゼ様２のアッセイおよびその使用の方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8680246B2 (en) * 2010-02-04 2014-03-25 Gilead Biologics, Inc. Antibodies that bind to lysyl oxidase-like 2 (LOXL2)
EP3348576A1 (en) * 2012-10-30 2018-07-18 Gilead Sciences, Inc. Therapeutic and diagnostic methods related to lysyl oxidase-like 2 (loxl2)

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014523521A (ja) * 2011-06-01 2014-09-11 ギリアード バイオロジックス， インコーポレイテッド リシルオキシダーゼ様２のアッセイおよびその使用の方法

Also Published As

Publication number Publication date
EP3596127A1 (en) 2020-01-22
WO2018167132A1 (en) 2018-09-20
GB201704206D0 (en) 2017-05-03
US20200123272A1 (en) 2020-04-23

Similar Documents

Publication Publication Date Title
Leeming et al. A serological marker of the N-terminal neoepitope generated during LOXL2 maturation is elevated in patients with cancer or idiopathic pulmonary fibrosis
JP2023527702A (ja) カルプロテクチンアッセイ
KR102862750B1 (ko) 콜라겐 타입 vii 알파 1 분석
Reese-Petersen et al. Evaluation of a novel biomarker of type XXVIII collagen formation, PRO-C28, in samples from cancer and heart failure with preserved ejection fraction patients
JP2023554465A (ja) コラーゲンｘｉバイオマーカーを検出するためのアッセイ
JP2020514369A (ja) リシルオキシダーゼ様２アッセイ
WO2017029300A1 (en) Immunoassay for collagen type viii sequences
JP7704771B2 (ja) Ｘｉｘ型コラーゲンのアッセイ
JP7752112B2 (ja) Ｉｖ型コラーゲンのプロテアーゼ媒介分解を測定するネオエピトープ特異的アッセイ
JP2023540617A (ja) がんを評価するためのアッセイ
US12560610B2 (en) Sparc assay
EP4430401B1 (en) Collagen type xxii assay
WO2020065078A1 (en) Type xi collagen assay
US20250012810A1 (en) Collagen type vii alpha 1 assay
JP6999653B2 (ja) ニドゲン－１フラグメントアッセイ
CN117501123A (zh) Xx型胶原蛋白测定
CN117083294A (zh) 用于检测胶原xviii生物标志物的测定
US20210080464A1 (en) SPARC Assay
CN111656192A (zh) 肿瘤抑素测定

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20210311

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20210311

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20211222

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20220105

RD01 Notification of change of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7426

Effective date: 20220525

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20220525

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20220726